FDA — authorised 12 October 2007
- Marketing authorisation holder: SHIONOGI INC
- Status: approved
🇺🇸 Doribax in United States
FDA authorised Doribax on 12 October 2007
Marketing authorisations
FDA — authorised 12 October 2007
- Application: NDA022106
- Marketing authorisation holder: SHIONOGI
- Local brand name: DORIBAX
- Indication: INJECTABLE — INTRAVENOUS
- Status: approved
Doribax in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Doribax approved in United States?
Yes. FDA authorised it on 12 October 2007; FDA authorised it on 12 October 2007.
Who is the marketing authorisation holder for Doribax in United States?
SHIONOGI INC holds the US marketing authorisation.